NSE · ZIMLAB
Zim Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,698
of 5,004 stocks
🏆 New peak
▲ 261W
Peak #1,698 · 01 Oct 2026
Zim Laboratories Limited, a smallcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip.
Market Cap
738.82 Cr
P/E Ratio
115.94
P/B Ratio
2.49
ROE
1.97%
ROCE
6.14%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 94.18 Cr | 105.27 Cr | 108.66 Cr | 88.71 Cr |
| Net Profit | -4.02 Cr | 3.74 Cr | 4.40 Cr | -42.46 L |
| EPS | -0.75 | 0.76 | 0.90 | -0.09 |
| Operating Profit | -1.93 Cr | 8.25 Cr | 9.48 Cr | 2.82 Cr |
Shareholding pattern
Promoter
30.36%
Public
69.64%
Mutual fund holdings
₹7.74
Cr total
1
Schemes
1
Fund Houses
₹7.74 Cr
Total Exposure
Tata Mutual Fund₹7.74 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Jun 2024 | Other | Annual General Meeting |
| 03 Jul 2023 | Other | Annual General Meeting |
| 22 Dec 2022 | Bonus | Bonus 2:1 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.